Scholarlink

<Emphasis Type="BoldItalic">BACKGROUND</Emphasis>: <p>Tonsil-derived mesenchymal stem cells (TMSCs) are widely used in regenerative medicine due to their high proliferative capacity and differentiation potential. However, their origin from immunological gateways exposes them to pathogens, raising concern about viral contamination during cell preparation. Understanding how these pathogens affect the biological and immunological properties of TMSCs is crucial for ensuring the safety and consistency of cell-based therapies. This study evaluated TMSC susceptibility and molecular responses to mammalian orthoreovirus (MRV).</p> <Emphasis Type="BoldItalic">METHODS:</Emphasis> <p>MRV infectivity in TMSCs and the innate immune responses were investigated using RNA-seq. Viral replication was confirmed by viral titration, L1 segment RT-PCR, and transcriptome mapping. Cellular impact was assessed using Live/Dead assays and protein–protein interaction network analysis.</p> <Emphasis Type="BoldItalic">RESULTS:</Emphasis> <p>TMSCs were infected with MRV strains to evaluate their susceptibility. Although no significant cytopathic effects were observed, the cells exhibited high viral permissivity to MRV, with stable viral titers of 3.9–5.5 log TCID<sub>50</sub>/ml and positive L1 gene segment RT-PCR. RNA-seq confirmed active replication, with reads successfully mapped to the MRV genome. Transcriptomic profiling showed robust induction of antiviral and stress response genes, including HSPA6, <i>PEG10</i>, <i>OASL</i>, and <i>IFIT2</i>. Gene set enrichment and protein network analyses highlighted enrichment of viral defense pathways and identified <i>IL1B</i>, <i>ISG15</i>, and <i>RSAD2</i> as key hub genes driving the host inflammatory immune response.</p> <Emphasis Type="BoldItalic">CONCLUSION:</Emphasis> <p>MRV establishes a permissive but non-cytopathic infection in TMSCs, triggering innate immune activation through upregulation of <i>IL1B</i>, <i>ISG15</i>, and <i>RSAD2</i>. This virus-induced shift from a quiescent to an immunomodulatory phenotype may compromise therapeutic consistency. Because visual quality control fails to detect latent infections, rigorous viral monitoring during TMSC preparation is essential to ensure safety in clinical applications.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Non-Cytopathic Mammalian Orthoreovirus Infection Triggers Innate Immune Responses in Human Tonsil-Derived Mesenchymal Stem Cells: Implications for Cell Therapy Quality Control

  • 期刊论文

  • 发表日期：

    2026年7月17日

查看全文
  • Jeong Eun Kim,
  • Ji Yeong Noh,
  • Kyeong Eun Lee,
  • Young Il Lee,
  • Juyun Park,
  • Min Chan Kim,
  • Da Hyeon Choi,
  • Hye Ji Jung,
  • Hee Sung Jung,
  • Jung Won Park,
  • Eun-Ok Lee,
  • Van Thi Lo,
  • Hye Kwon Kim,
  • Yoon Shin Park

摘要

BACKGROUND:

Tonsil-derived mesenchymal stem cells (TMSCs) are widely used in regenerative medicine due to their high proliferative capacity and differentiation potential. However, their origin from immunological gateways exposes them to pathogens, raising concern about viral contamination during cell preparation. Understanding how these pathogens affect the biological and immunological properties of TMSCs is crucial for ensuring the safety and consistency of cell-based therapies. This study evaluated TMSC susceptibility and molecular responses to mammalian orthoreovirus (MRV).

METHODS:

MRV infectivity in TMSCs and the innate immune responses were investigated using RNA-seq. Viral replication was confirmed by viral titration, L1 segment RT-PCR, and transcriptome mapping. Cellular impact was assessed using Live/Dead assays and protein–protein interaction network analysis.

RESULTS:

TMSCs were infected with MRV strains to evaluate their susceptibility. Although no significant cytopathic effects were observed, the cells exhibited high viral permissivity to MRV, with stable viral titers of 3.9–5.5 log TCID50/ml and positive L1 gene segment RT-PCR. RNA-seq confirmed active replication, with reads successfully mapped to the MRV genome. Transcriptomic profiling showed robust induction of antiviral and stress response genes, including HSPA6, PEG10, OASL, and IFIT2. Gene set enrichment and protein network analyses highlighted enrichment of viral defense pathways and identified IL1B, ISG15, and RSAD2 as key hub genes driving the host inflammatory immune response.

CONCLUSION:

MRV establishes a permissive but non-cytopathic infection in TMSCs, triggering innate immune activation through upregulation of IL1B, ISG15, and RSAD2. This virus-induced shift from a quiescent to an immunomodulatory phenotype may compromise therapeutic consistency. Because visual quality control fails to detect latent infections, rigorous viral monitoring during TMSC preparation is essential to ensure safety in clinical applications.

Graphical Abstract